GENPHARMASEC
|
GENPHARMASEC Last 5 Year Income Statement History
[Consolidated]
| Mar2024 | Mar2023 | |
|---|---|---|
| INCOME : | ||
| Gross Sales | ₹30 Cr | ₹26 Cr |
| Sales | ₹30 Cr | ₹26 Cr |
| Job Work/ Contract Receipts | - | - |
| Processing Charges / Service Income | - | - |
| Revenue from property development | - | - |
| Other Operational Income | - | - |
| Less: Excise Duty | - | - |
| Net Sales | ₹30 Cr | ₹26 Cr |
| EXPENDITURE : | ||
| Increase/Decrease in Stock | ₹0.83 Cr | ₹0.21 Cr |
| Raw Material Consumed | ₹23 Cr | ₹23 Cr |
| Opening Raw Materials | - | - |
| Purchases Raw Materials | - | - |
| Closing Raw Materials | - | - |
| Other Direct Purchases / Brought in cost | ₹23 Cr | ₹23 Cr |
| Other raw material cost | - | - |
| Power & Fuel Cost | - | - |
| Electricity & Power | - | - |
| Oil, Fuel & Natural gas | - | - |
| Coals etc | - | - |
| Other power & fuel | - | - |
| Employee Cost | ₹0.76 Cr | ₹0.54 Cr |
| Salaries, Wages & Bonus | ₹0.75 Cr | ₹0.52 Cr |
| Contributions to EPF & Pension Funds | - | - |
| Workmen and Staff Welfare Expenses | ₹0.01 Cr | ₹0.01 Cr |
| Other Employees Cost | - | - |
| Other Manufacturing Expenses | ₹0.58 Cr | ₹0.16 Cr |
| Sub-contracted / Out sourced services | - | - |
| Processing Charges | - | - |
| Repairs and Maintenance | - | - |
| Packing Material Consumed | - | - |
| Other Mfg Exp | ₹0.58 Cr | ₹0.16 Cr |
| General and Administration Expenses | ₹0.43 Cr | ₹0.54 Cr |
| Rent , Rates & Taxes | ₹0.18 Cr | ₹0.15 Cr |
| Insurance | ₹0.02 Cr | ₹0.01 Cr |
| Printing and stationery | - | - |
| Professional and legal fees | ₹0.18 Cr | ₹0.34 Cr |
| Traveling and conveyance | - | - |
| Other Administration | ₹0.05 Cr | ₹0.03 Cr |
| Selling and Distribution Expenses | ₹2.06 Cr | ₹0.22 Cr |
| Advertisement & Sales Promotion | - | - |
| Sales Commissions & Incentives | - | - |
| Freight and Forwarding | ₹0.05 Cr | ₹0.02 Cr |
| Handling and Clearing Charges | ₹0.00 Cr | - |
| Other Selling Expenses | ₹2.01 Cr | ₹0.20 Cr |
| Miscellaneous Expenses | ₹2.29 Cr | ₹0.40 Cr |
| Bad debts /advances written off | ₹0.42 Cr | ₹0.07 Cr |
| Provision for doubtful debts | - | - |
| Losson disposal of fixed assets(net) | - | - |
| Losson foreign exchange fluctuations | - | - |
| Losson sale of non-trade current investments | - | - |
| Other Miscellaneous Expenses | ₹1.87 Cr | ₹0.33 Cr |
| Less: Expenses Capitalised | - | - |
| Total Expenditure | ₹30 Cr | ₹25 Cr |
| Operating Profit (Excl OI) | ₹0.05 Cr | ₹0.26 Cr |
| Other Income | ₹0.66 Cr | ₹0.10 Cr |
| Interest Received | ₹0.47 Cr | ₹0.03 Cr |
| Dividend Received | - | - |
| Profit on sale of Fixed Assets | - | - |
| Profits on sale of Investments | - | - |
| Provision Written Back | - | - |
| Foreign Exchange Gains | ₹0.18 Cr | ₹0.06 Cr |
| Others | - | ₹0.02 Cr |
| Operating Profit | ₹0.70 Cr | ₹0.36 Cr |
| Interest | ₹0.41 Cr | ₹0.06 Cr |
| InterestonDebenture / Bonds | - | - |
| Interest on Term Loan | - | - |
| Intereston Fixed deposits | - | - |
| Bank Charges etc | - | - |
| Other Interest | ₹0.41 Cr | ₹0.06 Cr |
| PBDT | ₹0.29 Cr | ₹0.30 Cr |
| Depreciation | ₹0.04 Cr | ₹0.02 Cr |
| Profit Before Taxation & Exceptional Items | ₹0.25 Cr | ₹0.28 Cr |
| Exceptional Income / Expenses | - | - |
| Profit Before Tax | ₹0.25 Cr | ₹0.28 Cr |
| Provision for Tax | ₹0.42 Cr | ₹-0.84 Cr |
| Current Income Tax | - | - |
| Deferred Tax | ₹0.42 Cr | ₹-0.84 Cr |
| Other taxes | - | - |
| Profit After Tax | ₹-0.17 Cr | ₹1.13 Cr |
| Extra items | - | - |
| Minority Interest | ₹0.04 Cr | - |
| Share of Associate | - | - |
| Other Consolidated Items | - | - |
| Consolidated Net Profit | ₹-0.13 Cr | ₹1.13 Cr |
| Adjustments to PAT | - | - |
| Profit Balance B/F | ₹-4.56 Cr | ₹-4.87 Cr |
| Appropriations | ₹-4.68 Cr | ₹-3.74 Cr |
| General Reserves | - | - |
| Proposed Equity Dividend | - | - |
| Corporate dividend tax | - | - |
| Other Appropriation | - | ₹0.82 Cr |
| Equity Dividend % | - | - |
| Earnings Per Share | - | ₹0.04 |
| Adjusted EPS | - | ₹0.02 |
Compare Income Statement of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹119.6 Cr | -3.6% | -27.5% | -49.1% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹6,661.8 Cr | -7.1% | -22.3% | 50.7% | Stock Analytics | |
| KIRI INDUSTRIES | ₹3,127.2 Cr | 4.5% | -1.1% | 40.8% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹2,247.5 Cr | -1.4% | -15.6% | 7.3% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,111.3 Cr | 11.7% | 19.9% | 71.9% | Stock Analytics | |
| BODAL CHEMICALS | ₹764.9 Cr | -0.9% | -3.8% | -27.6% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -3.6% |
-27.5% |
-49.1% |
| SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses
